Progress

Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases.

[Trends in UROLOGY & MENS HEALTH @TrendsMenHealth]

Halfway through 2024 already, so we thought we'd find our most popular articles published last year. Take a look - an excellent and varied selection!

Top 10 Trends articles 2023: https://t.co/hEp1f8NDv5

[Progress @progressnp]

Halfway through 2024 already, so we thought we'd find our most popular articles published last year. Take a look!

Top 10 Progress articles 2023: https://t.co/QNt5ua4GQn

[Progress @progressnp]

The latest issue of Progress has now published! Read articles on #diabetes within an EIP service, non-pharmacological interventions in adults with intellectual disability, managing clinical aspects of #dementia, and much more: https://t.co/wJx0RfzdZJ

[Progress @progressnp]

Psilocybin treatment for depression - new study looking into side effects.

Acute adverse effects of psilocybin in therapeutic use - Progress in Neurology and Psychiatry - Wiley Online Library https://t.co/gP6xvf9oB7

[Progress @progressnp]

A UK study involving 5,000 volunteers at memory clinics as begun, studying blood tests (such as p-tau217) to diagnose Alzheimer's disease and other forms of dementia at an early disease stage or with mild progressive memory disorders. https://t.co/ae0mwVlQFh

[Prescriber @PrescriberUK]

#Ganaxolone (#Ztalmy) has been granted a UK marketing authorisation for the treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (#CDKL5) deficiency disorder in children. https://t.co/qMpHUxYnTj

[Royal College of Psychiatrists @rcpsych]

RCPsych President @DrLadeSmith says it’s concerning to see mental health impairments are increasingly preventing people from working on the front page of The Times this morning.

She has called on Government to make tackling the mental health crisis a top priority.

[Prescriber @PrescriberUK]

The March issue of Prescriber is now out, featuring articles on prescribing #valproate safely, treating #actinickeratosis, prescribing in prisons and a Profile on Dr Alpana Mair, Head of Effective Prescribing and Therapeutics for the Scottish Government https://t.co/eDOujIL1OO

[Progress @progressnp]

Vitamin B12 deficiency can be difficult to recognise as the symptoms can vary from person to person and are often not exclusive to B12 deficiency.
NICE publishes new guideline on managing vitamin B12 deficiency - Prescriber - Wiley Online Library https://t.co/Wu80nVjtmS

[Progress @progressnp]

UK authorities impose restrictions on valproate use - Progress in Neurology and Psychiatry - Wiley Online Library https://t.co/x7D9M8R8fm

[Trends in UROLOGY & MENS HEALTH @TrendsMenHealth]

Check out our new issue of Trends articles and videos. Key topics include first responders, urethral imaging, catheter care, prostate cancer screening/guideline, creating a personal brand and managing patient information.

Browse the full issue here: https://t.co/r4aMF9hZcR

[Prescriber @PrescriberUK]

The MHRA has granted #rozanolixizumab (#Rystiggo) a marketing authorisation for the treatment of generalised #myasthenia gravis https://t.co/0fFzxCPw0l

[Progress @progressnp]

The FDA has delayed action for Alzheimer’s treatment donanemab, Eli Lilly announced. The drug company said FDA would wait on ruling about donanemab until after the first quarter of 2024 as the agency want to further understand topics related to safety and efficacy of donanemab.

[Progress @progressnp]

Check out the last issue of Progress in Neurology and Psychiatry! Read about applying STOPPFrail criteria in patients with dementia, guideline adherence in lithium prescribing and monitoring, use of pregabalin in treating challenging behaviour in ID and much more. #dementia

[Progress @progressnp]

Leading UK charity has voiced concerns Alzheimer's patients could lose out on pioneering new drugs lecanemab and donanemab for treatment of early disease as very few clinicians have access to the specialist scans and investigations needed. @AlzResearchUK https://t.co/AXttZMtGWH

[Progress @progressnp]

Check out the new safety and educational materials issued to support safe prescribing of valproate in Prescriber at Wiley Online Library
#epilepsy #bipolar

https://t.co/vd5v6MjKpU

[Progress @progressnp]

Most notable news in Neurology in 2023 https://t.co/Enf24OoHSA

[Trends in UROLOGY & MENS HEALTH @TrendsMenHealth]

Check out our new issue of Trends articles and videos. Key topics include men's use of primary care, prostatic abscesses, heart failure, upper urinary tract cancer, retroperitoneal fibrosis and NHS whistleblowing.

Browse the full issue here: https://t.co/Nuc60pxm1i

[Progress @progressnp]

The CHMP has recently adopted positive opinions on new medicines for a range of conditions, including myasthenia gravis, NSCLC, Friedreich's ataxia and ulcerative colitis

Wiley Online Library https://t.co/V6rLDPASn0

[Progress @progressnp]

Switching anti-CGRP agents may improve migraine control - Progress in Neurology and Psychiatry - Wiley Online Library https://t.co/lo7MJdMetP

#migraine